dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Cuidin Mihai, Andreea |
dc.contributor.author | Sánchez, Marta |
dc.contributor.author | Hernández Hernández, Irene |
dc.contributor.author | Cordero Vázquez, Efráin Santiago |
dc.contributor.author | Fidilio Meli, Enzamaría |
dc.contributor.author | Gonzalez Junyent, Carla |
dc.contributor.author | Lopez Martin, Natividad |
dc.contributor.author | Vilallonga Puy, Ramón |
dc.contributor.author | Ferrer Costa, Roser |
dc.contributor.author | Hernández Pascual, Cristina |
dc.contributor.author | Simó Canonge, Rafael |
dc.contributor.author | Comas Martínez, Marta |
dc.contributor.author | Giralt Arnaiz, Marina |
dc.date.accessioned | 2021-12-27T13:23:42Z |
dc.date.available | 2021-12-27T13:23:42Z |
dc.date.issued | 2021-06 |
dc.identifier.citation | Ciudin A, Sánchez M, Hernandez I, Cordero E, Fidilio E, Comas M, et al. Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study. Obes Facts. 2021 Jun;14:291–297. |
dc.identifier.issn | 1662-4025 |
dc.identifier.uri | https://hdl.handle.net/11351/6737 |
dc.description | Cirurgia bariàtrica; Teràpia farmacològica; Hipoglucèmia postprandial |
dc.description.sponsorship | There were no funding sources. |
dc.language.iso | eng |
dc.publisher | Karger |
dc.relation.ispartofseries | Obesity Facts;14 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Hipoglucèmia - Tractament |
dc.subject | Obesitat - Cirurgia - Complicacions |
dc.subject.mesh | Hypoglycemia |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Gastric Bypass |
dc.subject.mesh | /adverse effects |
dc.title | Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1159/000515598 |
dc.subject.decs | hipoglucemia |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | derivación gástrica |
dc.subject.decs | /efectos adversos |
dc.relation.publishversion | https://doi.org/10.1159/000515598 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Ciudin A, Hernández C, Simó R] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Barcelona, Spain. Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Sánchez M] Endocrinology and Nutrition Department, Hospital Universitario Gran Canaria Doctor Negrín, Las Palmas, Spain. [Hernandez I, Cordero E, Comas M, Lopez N] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Fidilio E] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Gonzalez C] Servei d’Angioradiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Vilallonga R] Unitat de Cirurgia Endocrina, Metabòlica i Bariàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Giralt M] Servei de Bioquímica Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Ferrer R] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Bioquímica Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 33965935 |
dc.identifier.wos | 000652267700001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |